Total Funding
60
56
Total FundingSeries B raised
Growth Score
-8 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
24887
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
- Jorge A. Quiroz: Executive Vice President & Chief Medical Officer
- Ana de Vera: CMO
About the Company
NMD Pharma is a clinical-stage biotech company that delivers life-transforming therapies for people living with neuromuscular diseases. They use ClC-1 Cl- ion channel inhibitors to treat neuromuscular diseases. Their translational muscle electrophysiology platform leverages in-depth knowledge of muscle physiology and muscular disorders to identify
and develop first-class therapeutics for neuromuscular diseases that are unmet medically.
